S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract

Completed · Phase 2

Conditions studied: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer

In brief

RATIONALE: Biological therapies such as ZD 1839 may interfere with the growth of the tumor cells and slow the growth of cancer of the urinary tract. PURPOSE: Phase II trial to study the effectiveness of ZD 1839 in treating patients who have advanced cancer of the urinary tract.

Key facts

Study ID
NCT00014144
Run by
SWOG Cancer Research Network
People needed
31
Starts
2001-02-01
Expected to finish
2007-12-01
Last updated by the study team
2012-10-08

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.